News | Computed Tomography (CT) | April 18, 2025

First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications.

NANO-X ARC

April 17, 2025 — NANO-X IMAGING LTD has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Nanox.ARC X, its new multi-source digital tomosynthesis system.

The FDA 510(k) clearance was received in less than 30 days from the date of submission and covers the production of tomographic images for general use, including the human musculoskeletal system and pulmonary, intra-abdominal and paranasal sinus indications, adjunctive to conventional radiography on adult patients.

The Nanox.ARC X maintains the Nanox.ARC’s proprietary digital Nanox.SOURCE and advanced tomosynthesis technology with a cold cathode, which enables it to create a more comprehensive, sliced three-dimensional view of the body, enhance visualization with multiple layers of images, and reduce the super-imposition of structures often seen in 2D X-rays. The Nanox.ARC X introduces a fully integrated, single-unit system with a streamlined design that significantly reduces the physical footprint. The system features 'plug and play' one-day installation capability, making advanced tomosynthesis technology more accessible to diverse healthcare settings with space constraints.

“The FDA clearance of the Nanox.ARC X marks an important evolution in our imaging technology,” said Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox. “By integrating our proprietary digital technology in this new imaging system, we’re making it easier for healthcare providers to adopt digital 3D imaging. This milestone advances our mission to expand access to essential medical imaging technology to more patients, regardless of their location. We look forward to introducing further capabilities to the Nanox.ARC X in the future and making them available through remote and immediate upgrades.”

The Nanox.ARC X is designed to be installed in any standard X-ray shielded room with minimal infrastructure requirements. The system operates on standard power (110v/230v 16A) and features a cables-free design for enhanced user and patient safety, ease of cleaning, and maintenance.

Nanox will offer the Nanox.ARC X system, later this year, alongside the current Nanox.ARC, expanding the Company’s product portfolio to meet diverse customer needs and use cases.

For more information about Nanox's complete suite of medical imaging products, please visit www.nanox.vision.


Related Content

News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Breast Imaging

April 15, 2025 — CureMetrix, a provider of AI-driven medical imaging solutions, has announced that its AI-based cmAngio ...

Time April 17, 2025
arrow
News | PACS

April 3, 2025 – Konica Minolta Healthcare Americas, Inc. has launched the next-generation of the Exa Platform with the ...

Time April 15, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiation Dose Management

April 7, 2025 — DOSIsoft, a provider of patient-specific imaging and dosimetry software solutions, recently announced ...

Time April 08, 2025
arrow
News | Prostate Cancer

March 28, 2025 — Novartis has announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu ...

Time March 31, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | Computed Tomography (CT)

March 10, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for its Naeotom Alpha class of ...

Time March 11, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Prenuvo has announced FDA clearance for its AI-powered Prenuvo Body Composition report, marking a significant milestone ...

Time February 13, 2025
arrow
News | Prostate Cancer

Feb. 10, 2025 —Ibex Medical Analytics recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 10, 2025
arrow
Subscribe Now